Use of cyclosporine in hematopoietic cell transplantation

William Hogan, R. Storb

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Early attempts to perform successful allogeneic hematopoietic stem cell transplants were plagued by graft rejection and graft-versus-host disease, leading many investigators to lose hope that bone marrow transplantation could ever become a useful therapeutic approach in clinical medicine. Although many subsequent discoveries contributed to the successful transformation of this area of research into lifesaving therapy, there can be no doubt that the discovery of cyclosporine (CsA) constituted one of the major advances. Even today, more than 25 years after the first description of its use in humans, CsA remains one of the cornerstones of therapy for the majority of patients undergoing allogeneic hematopoietic cell transplantation (HCT). In this review we will recount the events that have established CsA as a foundation of HCT.

Original languageEnglish (US)
JournalTransplantation Proceedings
Volume36
Issue number2 SUPPL.
DOIs
StatePublished - Mar 2004

Fingerprint

Cell Transplantation
Cyclosporine
Clinical Medicine
Graft Rejection
Graft vs Host Disease
Hematopoietic Stem Cells
Bone Marrow Transplantation
Therapeutics
Research Personnel
Transplants
Research

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Use of cyclosporine in hematopoietic cell transplantation. / Hogan, William; Storb, R.

In: Transplantation Proceedings, Vol. 36, No. 2 SUPPL., 03.2004.

Research output: Contribution to journalReview article

@article{858400ed874847b79113d2b2dfcd6dc9,
title = "Use of cyclosporine in hematopoietic cell transplantation",
abstract = "Early attempts to perform successful allogeneic hematopoietic stem cell transplants were plagued by graft rejection and graft-versus-host disease, leading many investigators to lose hope that bone marrow transplantation could ever become a useful therapeutic approach in clinical medicine. Although many subsequent discoveries contributed to the successful transformation of this area of research into lifesaving therapy, there can be no doubt that the discovery of cyclosporine (CsA) constituted one of the major advances. Even today, more than 25 years after the first description of its use in humans, CsA remains one of the cornerstones of therapy for the majority of patients undergoing allogeneic hematopoietic cell transplantation (HCT). In this review we will recount the events that have established CsA as a foundation of HCT.",
author = "William Hogan and R. Storb",
year = "2004",
month = "3",
doi = "10.1016/j.transproceed.2004.01.043",
language = "English (US)",
volume = "36",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Use of cyclosporine in hematopoietic cell transplantation

AU - Hogan, William

AU - Storb, R.

PY - 2004/3

Y1 - 2004/3

N2 - Early attempts to perform successful allogeneic hematopoietic stem cell transplants were plagued by graft rejection and graft-versus-host disease, leading many investigators to lose hope that bone marrow transplantation could ever become a useful therapeutic approach in clinical medicine. Although many subsequent discoveries contributed to the successful transformation of this area of research into lifesaving therapy, there can be no doubt that the discovery of cyclosporine (CsA) constituted one of the major advances. Even today, more than 25 years after the first description of its use in humans, CsA remains one of the cornerstones of therapy for the majority of patients undergoing allogeneic hematopoietic cell transplantation (HCT). In this review we will recount the events that have established CsA as a foundation of HCT.

AB - Early attempts to perform successful allogeneic hematopoietic stem cell transplants were plagued by graft rejection and graft-versus-host disease, leading many investigators to lose hope that bone marrow transplantation could ever become a useful therapeutic approach in clinical medicine. Although many subsequent discoveries contributed to the successful transformation of this area of research into lifesaving therapy, there can be no doubt that the discovery of cyclosporine (CsA) constituted one of the major advances. Even today, more than 25 years after the first description of its use in humans, CsA remains one of the cornerstones of therapy for the majority of patients undergoing allogeneic hematopoietic cell transplantation (HCT). In this review we will recount the events that have established CsA as a foundation of HCT.

UR - http://www.scopus.com/inward/record.url?scp=1642396546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642396546&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.01.043

DO - 10.1016/j.transproceed.2004.01.043

M3 - Review article

C2 - 15041370

AN - SCOPUS:1642396546

VL - 36

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2 SUPPL.

ER -